SCHEMBL6907670

SCHEMBL6907670

COc1ccc(C2CNC(=O)C2)c(OC2CCCC2)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 14/20 0.62
PDE4B Q07343 13/20 0.62
PDE4C Q08493 10/20 0.62
PDE4D Q08499 10/20 0.62
CYP3A4 P08684 2/20 0.62
VEGFA P15692 1/20 0.62
ALDH1A1 P00352 1/20 0.62
LMNA P02545 1/20 0.62
CYP1A2 P05177 1/20 0.62
MAPT P10636 1/20 0.62
CYP2C9 P11712 1/20 0.62
ALOX15 P16050 1/20 0.62
CREBBP Q92793 1/20 0.62
KDM4E B2RXH2 1/20 0.62
PDE5A O76074 1/20 0.62
TNF P01375 1/20 0.62
MAPK1 P28482 1/20 0.62
BLM P54132 1/20 0.62
PDE1A P54750 1/20 0.62
PDE1B Q01064 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6052153 0.88 MTNR1A (0.57) PDE4APDE4BPDE4CPDE4DCYP3A4
SCHEMBL3544677 0.80 MTNR1A (0.51) PDE4APDE4BPDE4CPDE4DCYP3A4
SCHEMBL3546305 0.79 MTNR1A (0.55) PDE4APDE4BPDE4CPDE4DCYP3A4
SCHEMBL18117796 0.78 MTNR1A (0.66) PDE4APDE4BPDE4CPDE4DCYP3A4
SCHEMBL19559337 0.78 MTNR1A (0.66) PDE4APDE4BPDE4CPDE4DCYP3A4
SCHEMBL10701867 0.77 CA2 (0.46) PDE4APDE4BPDE4CPDE4DCYP3A4
SCHEMBL18117756 0.77 MTNR1A (0.64) PDE4APDE4BPDE4CPDE4DCYP3A4
SCHEMBL19559348 0.77 MTNR1A (0.64) PDE4APDE4BPDE4CPDE4DCYP3A4
SCHEMBL19559399 0.77 MTNR1A (0.64) PDE4APDE4BPDE4CPDE4DCYP3A4
SCHEMBL18117787 0.77 MTNR1A (0.64) PDE4APDE4BPDE4CPDE4DCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0758233-B1 PDE IV INHIBITORS FOR TREATING MULTIPLE SCLEROSIS SCHERING AG (DE) 2003-12-03 EP claimed
EP-0758233-A1 PDE IV INHIBITORS FOR TREATING MULTIPLE SCLEROSIS SCHERING AKTIENGESELLSCHAFT (DE) 1997-02-19 EP claimed
WO-1995028926-A1 PDE IV INHIBITORS FOR TREATING MULTIPLE SCLEROSIS SCHERING AKTIENGESELLSCHAFT (DE) 1995-11-02 WO claimed
EP-1380291-A1 PDE IV inhibitors for treating multiple sclerosis Schering Aktiengesellschaft (DE) 2004-01-14 EP disclosed
EP-0758233-B1 PDE IV INHIBITORS FOR TREATING MULTIPLE SCLEROSIS SCHERING AG (DE) 2003-12-03 EP disclosed
WO-2002051502-A1 COMBINED INHIBITION OF PHOSPHODIESTERASE-4 (PDE-4) AND PHOSPHODIESTERASE-3 (PDE-3) AS A THERAPY FOR TH1-MEDIATED AUTOIMMUNE DISEASES THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2002-07-04 WO disclosed
US-6060501-A ADMINISTERING SYNERGISTIC MIXTURE OF A PHOSPHODIESTERASE INHIBITOR AND AN INTERFERON SCHERING AKTIENGESELLSCHAFT (DE) 2000-05-09 US disclosed
EP-0758233-A1 PDE IV INHIBITORS FOR TREATING MULTIPLE SCLEROSIS SCHERING AKTIENGESELLSCHAFT (DE) 1997-02-19 EP disclosed
WO-1995028926-A1 PDE IV INHIBITORS FOR TREATING MULTIPLE SCLEROSIS SCHERING AKTIENGESELLSCHAFT (DE) 1995-11-02 WO disclosed